Notice of AGM & Posting of Annual Report
02/06/2023 08:51
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230602:nRSB4896Ba&default-theme=true
RNS Number : 4896B Instem plc 02 June 2023
Instem plc
("Instem", or the "Company")
Notice of AGM
Posting of Annual Report
Instem plc (AIM: INS), a leading provider of IT solutions to the global life
sciences market, announces that it has posted to shareholders its Annual
Report and Accounts for the year ended 31 December 2022, together with the
Notice of Annual General Meeting which is to be held at the offices of the
Company at 2 Diamond Way, Stone Business Park, Stone, Staffordshire, ST15 0SD
on 27(th) June 2023 at 2.30 p.m.
A copy of the Annual Report and Accounts and Notice of Annual General meeting
is available on Instem's website.
For further information, please contact:
Instem plc Via Walbrook
Phil Reason, CEO
Nigel Goldsmith, CFO
Singer Capital Markets (Nominated Adviser & Broker) +44 (0) 20 7496 3000
Peter Steel
Alex Bond
Stifel Nicolaus Europe Limited (Joint Broker) +44 (0) 20 7710 7600
Ben Maddison
Richard Short
Walbrook Financial PR +44 (0) 20 7933 8780
Tom Cooper instem@walbrookpr.com
Nick Rome
Joe Walker
About Instem
Instem is a leading provider of IT solutions & services to the life
sciences market delivering compelling solutions for Study Management,
Regulatory Submissions, Clinical Trial Acceleration, and Informatics-based
Insight Generation.
Instem solutions are in use by over 700 customers worldwide, including all of
the largest 25 pharmaceutical companies, enabling clients to bring life
enhancing products to market faster. Instem's portfolio of software solutions
increases client productivity by automating study-related processes while
offering the unique ability to generate new knowledge through the extraction
and harmonisation of actionable scientific information.
Instem products and services address aspects of the entire drug development
value chain, from discovery through to market launch. Management estimate that
over 50% of all drugs on the market have been through some part of Instem's
platform during their development.
To learn more about Instem solutions and its mission, please
visit www.instem.com (http://www.instem.com/)
About eTRANSAFE
The "Enhancing TRANslational SAFEty Assessment through Integrative Knowledge
Management (eTRANSAFE)" project develops an integrative data infrastructure
and innovative computational methods and tools that aim to drastically improve
the feasibility and reliability of translational safety assessment during the
drug development process. This infrastructure will be underpinned by
development of open standards and robust policies widely accepted by
stakeholders, including regulatory agencies and international organisations.
The eTRANSAFE is a 5.5-year project, started on 1st September of 2017, funded
by the Innovative Medicines Initiative 2 Joint Undertaking (IMI 2) together
with the pharmaceutical industry, that aims to develop an advanced data
integration infrastructure together with innovative computational methods to
improve the security in drug development process.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACSUUSBROKUNRRR